Welcome to our dedicated page for F5 SEC filings (Ticker: FFIV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
F5, Inc. filings document regulatory disclosures for an application delivery and security company with products and services used across enterprise, service provider, and government markets. Recent Form 8-K reports furnish quarterly results, financial-condition updates, Regulation FD materials, board appointments, director compensation arrangements, and material cybersecurity incident disclosures involving company systems and product-development environments.
The company’s proxy materials cover director elections, shareholder voting results, executive compensation, equity incentive plans, non-employee director compensation, auditor ratification, and governance practices. These filings also describe common-stock authorization for incentive awards, committee assignments, exhibits to earnings releases, and other public-company reporting matters.
F5, Inc. director Julie Marie Gonzalez reported routine equity compensation activity. On March 12, 2026, she received a grant of 987 Restricted Stock Units (RSUs), each representing a right to receive one share of F5 common stock upon vesting, contingent on her continued board service through specified annual shareholder meeting dates.
On March 11, 2026, she exercised 934 RSUs, converting them into 934 shares of common stock at no cash exercise price. Following these transactions, she holds 1,414 shares of F5 common stock directly. The filing shows no open-market purchases or sales, only grants and RSU conversions.
F5, Inc. director Tami A. Erwin reported routine equity compensation activity. She received a grant of 987 Restricted Stock Units (RSUs), each representing one share of F5 common stock, at a stated price of $0.00 per unit.
On the prior day, she exercised 934 RSUs, converting them into 934 shares of common stock. After these transactions, she holds 2,842 shares of F5 common stock directly and an additional 5 shares indirectly through a trust where she and her spouse are grantors, trustees, and beneficiaries. The new RSUs will fully vest on the business day before the fiscal 2026 annual shareholder meeting if she continues serving as a director through the vest date.
F5, Inc. director Michael L. Dreyer exercised restricted stock units into common shares. On this transaction date, 934 Restricted Stock Units were converted into 934 shares of F5 common stock at a stated price of $0.00 per share, reflecting equity compensation rather than an open-market purchase.
After the conversion, Dreyer directly owned 2,243 shares of F5 common stock. Footnotes explain that each Restricted Stock Unit represents a contingent right to receive one share of common stock, generally issued if the director continues to serve through the applicable vesting date tied to the company’s fiscal 2025 annual shareholder meeting.
F5, Inc. director Michel Combes reported equity compensation activity. On March 11, 2026, he exercised 934 restricted stock units, receiving 934 shares of common stock at a conversion price of $0.00 per share, bringing his direct common stock holdings to 5,805 shares.
On March 12, 2026, he received a grant of 987 restricted stock units. Each unit represents a right to one share of F5 common stock. According to the award terms, these units will fully vest on the first business day before the fiscal 2026 annual shareholder meeting (to be held in 2027), provided he continues serving as a director through the vest date.
Director Elizabeth Buse of F5, Inc. reported compensation-related equity activity. She received a grant of 987 Restricted Stock Units (RSUs), each representing one share of common stock upon vesting. These RSUs will fully vest on the first business day before the annual shareholder meeting for fiscal 2026, to be held in 2027, if she continues serving as a director through the vest date.
On a separate date, she exercised 934 RSUs, which converted into 934 shares of F5 common stock at a price of $0.00 per share. Following this exercise, she directly holds 5,947 shares of common stock. No open‑market purchases or sales were reported; the transactions reflect equity awards and RSU vesting.
F5, Inc. director Marianne Budnik reported equity compensation activity. She received a grant of 987 Restricted Stock Units (RSUs) on Common Stock, each representing a right to one share when vested. These RSUs will fully vest on the first business day before the fiscal 2026 annual shareholder meeting if she continues serving as a director.
On a separate date, she exercised 934 RSUs into 934 shares of Common Stock at a price of $0.00 per share, reflecting the conversion of previously granted RSUs rather than an open-market purchase. After these transactions, she directly holds 2,141 shares of Common Stock. The filing shows only acquisitions and no share sales, indicating routine director compensation and vesting.
F5, Inc. reported results of its fiscal 2025 annual meeting held on March 12, 2026. Shareholders approved the new 2026 Incentive Award Plan, which includes 3,500,000 new shares of common stock issuable under the plan, along with previously available shares that moved into the new plan. The board also adopted a Non-Employee Director Compensation Program.
All eight director nominees were elected, the advisory vote on executive compensation was approved, and shareholders ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2026. A total of 52,050,157 common shares were present in person or by proxy and entitled to vote at the meeting.
F5, INC. executive Chad Michael Whalen, EVP, Worldwide Sales, reported an open-market sale of 688 shares of common stock on March 6, 2026 at an average price of $277.05 per share. After this transaction, he directly owned 26,329 shares. The sale was executed pursuant to a Rule 10b5-1 trading plan dated December 5, 2025.
F5, INC. Chief Financial Officer Werner Edward Cooper reported selling a total of 969 shares of F5 common stock in open-market transactions on March 4, 2026. The sales were executed under a pre-arranged Rule 10b5-1 trading plan dated December 3, 2025.
The shares were sold in several blocks at prices including $278.21, $280.56, $282.23, $284.74 and $286.39 per share. After these transactions, Cooper directly owned 5,305 shares of F5 common stock.